DrugScope Latest

New Jan-Feb issue of Druglink out now!

In this issue: In the January-February issue of Druglink we have a focus on 'new drugs' - those substances that have grown in popularity in the last five years such as ketamine, as well as the set of drugs being labelled 'legal highs'. Within this, we have a special two part investigation into mephedrone - a drug that is currently legal but looks set to be outlawed before the election. In addition, there are reports into the harsh treatment handed out to sports stars who are caught taking drugs, how homeless drug users are failed by a divided system and a successful trial of naloxone overdose kits. To find out more, click here

 

Druglink logo

 

DrugScope updates

More from Drugscope

If you'd like to sign up for updates about DrugScope's work please click here

 

DrugScope website

subscribe

 

 

DrugScope is pleased to present DS Daily in association with

DDN logo

See job vacancies on the DDN site here

 


 
Thanks to the following sponsors:

 

logo

logo

logo

Concateno logo

Conference Consortium logo

 

If you would like to sponsor DS Daily please contact us or call 020 75207550

 

 

 

 

Bookmark and Share

 



 


 

 

Terms of use

 

 

Disclaimer

This website is intended purely as an information resource. DrugScope does not guarantee the accuracy of the information provided by external sources/links, and accepts no responsibility or liability for any consequences arising from the use of such data. Furthermore, we cannot be held responsible for the privacy of data collected by websites not managed by DrugScope.

 

Terms and conditions

Access to and use of this site is provided by DrugScope subject to the following terms:

 

By using this site you agree to be legally bound by these terms, which shall take effect immediately on your first use of the site. If you do not agree to be legally bound by all the following terms please do not access and/or use the DrugScope website.

 

DrugScope may change these terms at any time by posting changes online. Please review these terms regularly to ensure you are aware of any changes. Your continued use of the DrugScope site after changes are posted means you agree to be legally bound by these terms as updated and/or amended.

 

Use of the DS Daily website

 

This site is the property of DrugScope and is protected by copyright. You may not copy, reproduce, republish, download, post, broadcast or otherwise use DS Daily conent in any way except for your own personal, non-commercial use. You also agree not to adapt, alter or create a derivative work from any DS Daily content except for your own personal, non-commercial use.

 

Those wishing to use the contents of this site for purposes other than their personal use are requested to apply in writing to the Webmaster, DrugScope, Prince Consort House, Suite 204 (2nd Floor), 109/111 Farringdon Road, London EC1R 3BW.

 

Links to this web site should not be made without the prior permission of DrugScope. Please contact Jackie Buckle, Webmaster, DrugScope, Prince Consort House, Suite 204 (2nd Floor), 109/111 Farringdon Road, London EC1R 3BW, or email: webmaster@drugscope.org.uk

 

In using the DS Daily site you agree to use it only for lawful purposes, and in a way that does not infringe the rights of, restrict or inhibit anyone else's use of the site.